BiotechTube

Metformin Hydrochloride ER

Phase 2Recruiting
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Sarcoma Metastatic

Conditions

Sarcoma Metastatic, Sarcoma, Soft Tissue

Trial Timeline

Mar 4, 2026 → Oct 1, 2033

NCT ID
NCT07291297

About Metformin Hydrochloride ER

Metformin Hydrochloride ER is a phase 2 stage product being developed by Atrium Therapeutics for Sarcoma Metastatic. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07291297. Target conditions include Sarcoma Metastatic, Sarcoma, Soft Tissue.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT07291297Phase 2Recruiting

Competing Products

20 competing products in Sarcoma Metastatic

See all competitors
ProductCompanyStageHype Score
Tc99m-tilmanoceptNavidea BiopharmaceuticalsPhase 1
25
Azenosertib + GemcitabineZentalis PharmaceuticalsPhase 1/2
33
Olaratumab + Doxorubicin + Ifosfamide + MesnaEli LillyPhase 1
33
CAB-AXL-ADC + PD-1 inhibitorBioAtlaPhase 1/2
33
AbemaciclibEli LillyPhase 2
52
Abemaciclib + PlaceboEli LillyPhase 3
77
cisplatin + doxorubicin hydrochloride + etoposide + ifosfamide + methotrexate + zoledronic acidChugai PharmaceuticalPhase 3
77
PLX3397 + sirolimusDaiichi SankyoPhase 1/2
41
exatecan mesylateDaiichi SankyoPhase 2
52
efatutazoneDaiichi SankyoPhase 2
52
soblidotinDaiichi SankyoPhase 2
52
exatecan mesylateDaiichi SankyoPhase 2
52
LinsitinibAstellas PharmaPhase 2
52
Fluzoparib+ DalpiciclibSun PharmaceuticalPhase 2
52
Anlotinib HydrochlorideSun PharmaceuticalPhase 2
52
Doxorubicin Hydrochloride Liposome+Irinotecan + Temozolomide+Irinotecan+VincristineSun PharmaceuticalPhase 2
52
irinotecan liposome (II) + temozolomide + fluzoparibSun PharmaceuticalPhase 2
52
Eribulin mesylate 1.4 mg/m^2 intravenous + Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or 1,200 mg/m^2 IVEisaiPhase 3
77
EribulinEisaiPhase 2
52
Lenvatinib + Ifosfamide + Etoposide + LenvatinibEisaiPhase 2
52

Other Products from Atrium Therapeutics

Rivastigmine + Placebo (for rivastigmine)Approved
77
Phenoxybenzamine + DoxazosinApproved
77
Ropivacaine HCL + Exparel + Epinephrine + Clonidine HCL + KetorolacPhase 3
69
DiclofenacPhase 2
44
VaccinePhase 2
44